Primary Pulmonary Coccidioidomycosis in Persons with Community Acquired Pneumonia in Endemic Areas

Background Coccidioidomycosis is a frequent cause of community acquired pneumonia (CAP) in endemic areas of the United States. Methods This observational study included persons ≥ 14 years of age with CAP at Arizona or California study sites. The primary outcome was prevalence of PPC among patients with CAP. Secondary outcomes included predictors of PPC among those with CAP and clinical improvement in PPC. Associations between the SAnds-PPC clinical score over time and receipt of antifungal therapy among those with PPC were analyzed in a linear mixed model. Results Among 496 participants with CAP, the prevalence of PPC was 23.4% (95% CI: 19.9, 27.3). The odds of having PPC decreased for each year increase in age (odds ratio [OR]: 0.98; 95% CI: 0.97, 1.00); was lower for females than males (OR: 0.55; 95% CI: 0.33, 0.93); and higher for Hispanic ethnicity versus non-Hispanic ethnicity (OR: 1.98; 95% CI: 1.08, 3.64) Among 215 participants with PPC, a 50% reduction in the SAnds-PPC score (clinical response) was achieved by 67% of participants by Day 85, respectively. A linear mixed model controlling for visit, age, site, ethnicity, race and asthma history did not detect a difference in the average SAnds-PPC scores over time between participants who did and did not receive antifungal therapy (Parameter Estimate 0.79; 95% CI: -0.09, 1.67). Conclusions This study ascertained a high prevalence of coccidioidomycosis among patients with CAP in endemic areas. This study was not designed to definitively determine the impact of antifungal therapy for PPC.

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2026-11-19
DOI
https://doi.org/10.1093/ofid/ofag749
Primary Topic
Fungal Infections and Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Primary Pulmonary Coccidioidomycosis in Persons with Community Acquired Pneumonia in Endemic Areas

Mohamed A. Fayed, Emmanuel B. Walter, Aneesh T. Narang, Yashika C. Johnson et al.
Open Forum Infectious Diseases
Fungal Infections and Studies
article

Primary Pulmonary Coccidioidomycosis in Persons with Community Acquired Pneumonia in Endemic Areas

Mohamed A. Fayed, Emmanuel B. Walter, Aneesh T. Narang, Yashika C. Johnson, Neil M. Ampel, Alice K. Henning, Aung K. Htoo, Susanna Naggie, Alison Wall, Royce H. Johnson, George R. Thompson, Arash Heidari, Jonathan Hien Truong, Fariba Donovan, John N. Galgiani, Grace N Davis, David Bronstein, Rana Shenoy, Soe Win, for the Study to Assess the Prevalence and Outcomes of Primary Pulmonary Coccidioidomycosis (SAnds-PPC) Study Group, Armen Arshakyan
article en

Abstract

Background Coccidioidomycosis is a frequent cause of community acquired pneumonia (CAP) in endemic areas of the United States. Methods This observational study included persons ≥ 14 years of age with CAP at Arizona or California study sites. The primary outcome was prevalence of PPC among patients with CAP. Secondary outcomes included predictors of PPC among those with CAP and clinical improvement in PPC. Associations between the SAnds-PPC clinical score over time and receipt of antifungal therapy among those with PPC were analyzed in a linear mixed model. Results Among 496 participants with CAP, the prevalence of PPC was 23.4% (95% CI: 19.9, 27.3). The odds of having PPC decreased for each year increase in age (odds ratio [OR]: 0.98; 95% CI: 0.97, 1.00); was lower for females than males (OR: 0.55; 95% CI: 0.33, 0.93); and higher for Hispanic ethnicity versus non-Hispanic ethnicity (OR: 1.98; 95% CI: 1.08, 3.64) Among 215 participants with PPC, a 50% reduction in the SAnds-PPC score (clinical response) was achieved by 67% of participants by Day 85, respectively. A linear mixed model controlling for visit, age, site, ethnicity, race and asthma history did not detect a difference in the average SAnds-PPC scores over time between participants who did and did not receive antifungal therapy (Parameter Estimate 0.79; 95% CI: -0.09, 1.67). Conclusions This study ascertained a high prevalence of coccidioidomycosis among patients with CAP in endemic areas. This study was not designed to definitively determine the impact of antifungal therapy for PPC.

Open Forum Infectious Diseases
Kaiser Permanente (US), University of Arizona (US), University of California, Los Angeles (US), Duke University (US), University of California, San Francisco (US), Kern Medical Center (US), Dignity Health (US), Emmes (United States) (US), University of California Davis Medical Center (US), BIO5 Institute (US), University of Arizona College of Medicine- Phoenix (US), Duke Clinical Research Institute (US), Morehouse School of Medicine (US)
Fungal Infections and Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon